Experimental type 1 diabetes metabolically rejuvenates CD8+ T cells for improved control of tumor growth through an IGF1-IGF1R axis
Sarkar, A.; Dhar, S.; Bera, S.; Chakravarti, M.; Verma, A.; Prasad, P.; Sultana, J.; Das, J.; Saha, A.; Bhuniya, A.; Guha, I.; Dasgupta, S.; Roy, S. S.; Banerjee, S.; Roy, S.; Bhar, D.; Storkus, W. J.; Baral, R.; Datta, D.; Bose, A.
Show abstract
AbstractEpidemiological studies suggest that patients with pre-existing type 1 diabetes (T1D) have a decreased risk of developing melanoma, prostate cancer, and breast cancer, although the underlying mechanism remains to be elucidated. In translational modelling, we observed that streptozotocin (STZ) induced T1D mice exhibited restricted melanoma and carcinoma (mammary, lung and colon) growth in association with extended overall survival. Tumor-infiltrating CD8+ T cells were found to be responsible for tumor growth restriction. Tumor infiltrating CD8+ T cells but not tumor cells themselves exhibited higher glycolytic and cytotoxic activities in T1D hosts. Such improved anti-tumor T cell function was linked to selective upregulated expression of insulin-like growth factor 1, insulin-like growth factor 1 receptor, and phospho-mTOR in CD8+ T cells in the TME. T1D patient derived CD8+ T cells displayed superior activation in vitro after tumor antigen stimulation vs. non-diabetic CD8+ T cells. Activation of T1D patient derived CD8+ T cells was sensitive to targeted antagonism of IGF1R and mTOR, supporting the operational involvement of the IGF1R-mTOR signaling axis. Our results suggest that selective activation of the intrinsic IGF1R-mTOR signaling axis in CD8+ T cells represents a preferred endpoint to achieving more effective immunotherapy outcomes and improved cancer patient management. SignificanceExperimental type 1 diabetes decelerates tumor growth through metabolic activation of cytotoxic T cells dependent on an IGF1R-mTOR signaling pathway. CD8+IGF1R+IGF1+ T cells play a crucial role in T1D dependent tumor control.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Hyperglycemia enhances cancer immune evasion by inducing alternative macrophage polarization through increased O-GlcNAcylation 95%
- IL-3-driven T cell-basophil crosstalk enhances anti-tumor immunity 95%
- Immune modulation of innate and adaptive responses restores immune surveillance and establishes anti-tumor immunological memory 94%
Similar papers in this journal
- B cell c-Maf signaling promotes tumor progression in animal models of pancreatic cancer and melanoma 95%
- The spontaneous neoantigen-specific CD4+ T cell response to a growing tumor is functionally and phenotypically diverse. 94%
- CXCR6 by increasing retention of memory CD8 T cells in the ovarian tumor microenvironment promotes immunosurveillance and control of ovarian cancer 94%
Similar papers in this journal
- Neoantigen Cancer Vaccines and Different Immune Checkpoint Therapies Each Utilize Both Converging and Distinct Mechanisms that in Combination Enable Synergistic Therapeutic Efficacy 94%
- Integrin αvβ8 on T cells is responsible for suppression of anti-tumor immunity in multiple syngeneic models and is a promising target for tumor immunotherapy 94%
- Cancer-associated adipocytes mediate CD8+T cell dysfunction via FGF21-driven lipolysis 93%
Similar papers in this journal
- Lack of consistent effect of dietary fiber on immune checkpoint blockade efficacy across diverse murine tumor models 94%
- The lipid phosphatase activity of PTEN dampens FRA1 expression via AKT/mTOR signaling to suppress melanoma 93%
- Natural killer cell regulation of breast cancer stem cells mediates metastatic dormancy. 93%
Similar papers in this journal
- CD4+ tumor-infiltrating lymphocytes secreting T cell-engagers induce regression of autologous patient-derived non-small cell lung cancer xenografts 94%
- CD39+ conventional CD4+ T cells with exhaustion traits and cytotoxic potential infiltrate tumors and expand upon CTLA-4 blockade 94%
- Antibody Targeting of B7-H4 Enhances the Immune Response in Urothelial Carcinoma 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.